Xtx Topco LTD Verastem, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $151,453 - $1.84 Million	164,623 Added 153.0%	272,219 $231,000
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.83 $82,974 - $148,866	81,348 Added 309.92%	107,596 $125,000
Q1 2022 May 13, 2022	BUY	$1.06 - $2.1 $27,822 - $55,120	26,248 New	26,248 $37,000
Q2 2021 Aug 12, 2021	SELL	$2.57 - $4.85 $103,627 - $195,561	-40,322 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.9 - $2.82 $76,611 - $113,708	40,322 New	40,322 $100,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.